speb/financial-data huggingface dataset:
Financial ratios for COKE — annual report dated 2025-12-31
Total revenue: 7228055000
Gross profit: 2872362000
Operating income: 950656000
Net income: 570582000
Capital expenditures: 305721000
Operating cash flow: 931904000
Depreciation & amortization: 218530000
Net tangible assets: -1677243000
Owner earnings: 483391000
Return on net tangible assets (%): -28.820570424202096
Capex to operating income (%): 32.15895129258112
Buffett classification: The Good
Stock price: 152.85
P/E ratio: 15.140110451959577
Shares outstanding: 56517334
Book value: -739723000
Market cap (USD): 8638674501.9
Debt to equity: -3.930175214235599
Current ratio: 1.2640456755240963
Quick ratio: 0.965991439383267
Effective tax rate (%): 26.178197428446488
Interest coverage ratio: 22.275083181030038
COGS to revenue (%): 60.2609277322876
SG&A to revenue (%): 26.586765042601364
Free cash flow (dilution-adjusted): 619589000
Buyback yield (%): 30.1670238811154
Retained earnings: -824046000
Inventory turnover: 12.947919298694117
Receivables turnover: 10.330412027092114
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.948137266916184
FCF margin (%): 8.572001734906555
Revenue growth (%): 4.758732098538548
Rule of 40 score: 13.330733833445104
Financial ratios for CSAI — quarterly report dated 2025-03-31
Total revenue: 737000
Gross profit: 330000
Operating income: -2438000
Net income: -2014000
Capital expenditures: 30000
Operating cash flow: -2401000
Depreciation & amortization: 15000
Net tangible assets: 6887000
Owner earnings: -2029000
Return on net tangible assets (%): -29.461303905909688
Buffett classification: The Gruesome
Stock price: 4.44
Shares outstanding: 24992242
Book value: 6887000
P/B ratio: 16.11232096413533
Market cap (USD): 110965554.48
Debt to equity: 0
Current ratio: 7.118918918918919
Quick ratio: 6.88018018018018
COGS to revenue (%): 55.359565807327
R&D to revenue (%): 104.34192672998644
SG&A to revenue (%): 256.9877883310719
Free cash flow (dilution-adjusted): -3058000
Buyback yield (%): 0
Retained earnings: -43369000
Inventory turnover: 1.539622641509434
Receivables turnover: 1.37243947858473
Capitalized R&D asset: 916400
ROCI (R&D-adjusted, %): -25.609485247638087
Rosenberg metric: 0.509090909090909
FCF margin (%): -414.92537313432837
Revenue growth (%): 67.5
Rule of 40 score: -347.42537313432837
Financial ratios for CSAI — quarterly report dated 2025-06-30
Total revenue: 1090000
Gross profit: 404000
Operating income: -1921000
Net income: -2010000
Capital expenditures: 120000
Operating cash flow: -1905000
Depreciation & amortization: 17000
Net tangible assets: 8060000
Owner earnings: -2113000
Return on net tangible assets (%): -26.21588089330025
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 24992242
Book value: 8060000
P/B ratio: 6.852711516129032
Market cap (USD): 55232854.82
Debt to equity: 0
Current ratio: 8.84630738522954
Quick ratio: 8.462075848303392
COGS to revenue (%): 62.93577981651376
R&D to revenue (%): 34.77064220183486
SG&A to revenue (%): 125.13761467889908
Free cash flow (dilution-adjusted): -2581000
Buyback yield (%): 0
Retained earnings: -45420000
Inventory turnover: 1.7818181818181817
Receivables turnover: 2.1975806451612905
Capitalized R&D asset: 966830
ROCI (R&D-adjusted, %): -22.134016038853062
Rosenberg metric: 0.09622886866059818
FCF margin (%): -236.78899082568807
Revenue growth (%): 47.89687924016282
Rule of 40 score: -188.89211158552524
Financial ratios for CSAI — quarterly report dated 2025-09-30
Total revenue: 1450471
Gross profit: 720000
Operating income: -1983000
Net income: -2062000
Capital expenditures: 106000
Operating cash flow: -1353000
Depreciation & amortization: 28000
Net tangible assets: 6793000
Owner earnings: -2140000
Return on net tangible assets (%): -31.503017812453997
Buffett classification: The Gruesome
Stock price: 1.26
Shares outstanding: 24992242
Book value: 6793000
P/B ratio: 4.635687460621228
Market cap (USD): 31490224.92
Debt to equity: 0
Current ratio: 4.444503171247358
Quick ratio: 4.274312896405919
COGS to revenue (%): 50.39742263030422
R&D to revenue (%): 30.74863268552077
SG&A to revenue (%): 101.48427648674121
Free cash flow (dilution-adjusted): -2091000
Buyback yield (%): 0
Retained earnings: -47484000
Inventory turnover: 2.270186335403727
Receivables turnover: 1.045007925072046
Capitalized R&D asset: 953700
ROCI (R&D-adjusted, %): -26.699540879772464
Rosenberg metric: 0.8337730870712401
FCF margin (%): -144.1600693843586
Revenue growth (%): 33.07073394495413
Rule of 40 score: -111.08933543940446
Financial ratios for CSAI — annual report dated 2025-12-31
Total revenue: 5066000
Gross profit: 1489000
Operating income: -8151000
Net income: -8462000
Capital expenditures: 315000
Operating cash flow: -6917000
Depreciation & amortization: 89000
Net tangible assets: 8910000
Owner earnings: -8688000
Return on net tangible assets (%): -97.50841750841751
Buffett classification: The Gruesome
Stock price: 0.81
Shares outstanding: 24992242
Book value: 8910000
P/B ratio: 2.272022
Market cap (USD): 20243716.02
Debt to equity: 0
Current ratio: 8.099834983498349
Quick ratio: 7.849009900990099
COGS to revenue (%): 70.60797473351757
R&D to revenue (%): 37.16936439005132
SG&A to revenue (%): 105.03355704697988
Free cash flow (dilution-adjusted): -9561000
Buyback yield (%): 0
Retained earnings: -51281000
Inventory turnover: 11.766447368421053
Receivables turnover: 5.796338672768878
Capitalized R&D asset: 3395840
ROCI (R&D-adjusted, %): -64.92039551952568
Rosenberg metric: 0.8807266982622433
FCF margin (%): -188.7287801026451
Revenue growth (%): 271.40762463343106
Rule of 40 score: 82.67884453078597
Financial ratios for CSAI — quarterly report dated 2025-12-31
Total revenue: 1788000
Gross profit: 35000
Operating income: -1807000
Net income: -1834000
Capital expenditures: 59000
Operating cash flow: -1258000
Depreciation & amortization: 29000
Net tangible assets: 8910000
Owner earnings: -1864000
Return on net tangible assets (%): -20.920314253647586
Buffett classification: The Gruesome
Stock price: 0.81
Shares outstanding: 24992242
Book value: 8910000
P/B ratio: 2.272022
Market cap (USD): 20243716.02
Debt to equity: 0
Current ratio: 8.099834983498349
Quick ratio: 7.849009900990099
COGS to revenue (%): 97.98657718120806
R&D to revenue (%): 25.279642058165546
SG&A to revenue (%): 53.691275167785236
Free cash flow (dilution-adjusted): -1831000
Buyback yield (%): 0
Retained earnings: -51281000
Inventory turnover: 5.7631578947368425
Receivables turnover: 2.045766590389016
Capitalized R&D asset: 875890
ROCI (R&D-adjusted, %): -18.19626693807785
Rosenberg metric: -1.5358744394618835
FCF margin (%): -102.40492170022371
Revenue growth (%): 23.27030323253619
Rule of 40 score: -79.13461846768752
Financial ratios for CSBBANK.NS — annual report dated 2022-03-31
Capital expenditures: 0
Depreciation & amortization: 5009692.733746539
Buffett classification: The Gruesome
Stock price: 2.784518000791244
Shares outstanding: 169477587
Market cap (USD): 471913391.7321641
Buyback yield (%): 0
Retained earnings: -26219847.02624291
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSBBANK.NS — annual report dated 2023-03-31
Total revenue: 200926406.82095006
Net income: 66670085.26187576
Capital expenditures: 9129780.755176615
Operating cash flow: 269364360.5359318
Depreciation & amortization: 5256954.933008526
Net tangible assets: 390210280.1461632
Owner earnings: 62797259.43970767
Return on net tangible assets (%): 16.093184273921576
Buffett classification: The Gruesome
Stock price: 2.985383678440926
P/E ratio: 7.588945178395846
Shares outstanding: 169477587
Book value: 390210280.146163
P/B ratio: 1.2966229949191337
Market cap (USD): 505955622.09135205
Debt to equity: 0.24440115738838974
Effective tax rate (%): 25.388159398655713
COGS to revenue (%): 0
SG&A to revenue (%): 0.4756833420445054
Free cash flow (dilution-adjusted): 259611218.0267966
Buyback yield (%): 0
Retained earnings: 25248696.71132765
Receivables turnover: 2.337680900026656
Capitalized R&D asset: 0
FCF margin (%): 129.20711723976723
Rule of 40 score: 129.20711723976723
Financial ratios for CSBBANK.NS — annual report dated 2024-03-31
Total revenue: 247131598.51301116
Net income: 67972406.76340088
Capital expenditures: 13874841.108046528
Operating cash flow: 213811871.92708957
Depreciation & amortization: 6661949.874085622
Net tangible assets: 456127449.33445257
Owner earnings: 60759515.52943997
Return on net tangible assets (%): 13.320732093211177
Buffett classification: The Gruesome
Stock price: 4.252639155470249
P/E ratio: 10.603229409832881
Shares outstanding: 169477587
Book value: 456127449.3344526
P/B ratio: 1.5801000871630224
Market cap (USD): 720727022.4508157
Debt to equity: 0.46202502293325437
Effective tax rate (%): 25.55940249676305
COGS to revenue (%): 0
SG&A to revenue (%): 0.4796852763817925
Free cash flow (dilution-adjusted): 198663988.48782828
Buyback yield (%): 0
Retained earnings: 74657680.7770716
Receivables turnover: 4.024328393475404
Capitalized R&D asset: 0
FCF margin (%): 80.38793488294816
Revenue growth (%): 22.996077232016376
Rule of 40 score: 103.38401211496453
Financial ratios for CSBBANK.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 494592689.91877687
Buffett classification: The Gruesome
Stock price: 3.7428332537028193
Shares outstanding: 169477587
Book value: 494592689.918777
P/B ratio: 1.2825226925312685
Market cap (USD): 634326348.3809127
Debt to equity: 0.5667478922798636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSBBANK.NS — annual report dated 2025-03-31
Total revenue: 286208791.2087912
Net income: 69417816.22632685
Capital expenditures: 35003507.131166704
Operating cash flow: -614393266.3081598
Depreciation & amortization: 8930324.994154781
Net tangible assets: 525804477.43745613
Owner earnings: 43344634.08931493
Return on net tangible assets (%): 8.24348896771628
Buffett classification: The Gruesome
Stock price: 3.527249387326409
P/E ratio: 8.611473932892103
Shares outstanding: 169477587
Book value: 525804477.43745613
P/B ratio: 1.1369049533862416
Market cap (USD): 597789714.9113082
Debt to equity: 1.1664288764235926
Effective tax rate (%): 25.7313671782172
COGS to revenue (%): 0
SG&A to revenue (%): 0.4331496632260857
Free cash flow (dilution-adjusted): -650637128.8286182
Buyback yield (%): 0
Retained earnings: 111794330.13794716
Receivables turnover: 3.8831004722884814
Capitalized R&D asset: 0
FCF margin (%): -227.3295401167374
Revenue growth (%): 15.812301191311509
Rule of 40 score: -211.5172389254259
Financial ratios for CSBBANK.NS — quarterly report dated 2025-03-31
Total revenue: 87998597.14753331
Net income: 22263268.64624737
Capital expenditures: 0
Net tangible assets: 525804477.43745613
Owner earnings: 22263268.64624737
Return on net tangible assets (%): 4.2341344742344
Buffett classification: The Gruesome
Stock price: 3.527249387326409
P/E ratio: 6.712735272725439
Shares outstanding: 169477587
Book value: 525804477.43745613
P/B ratio: 1.1369049533862416
Market cap (USD): 597789714.9113082
Debt to equity: 1.1664288764235926
Effective tax rate (%): 25.765962423013956
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 111794330.13794716
Receivables turnover: 1.193909497682175
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSBBANK.NS — quarterly report dated 2025-06-30
Total revenue: 73030657.61759888
Net income: 13877837.584835012
Capital expenditures: 0
Owner earnings: 13877837.584835012
Buffett classification: The Gruesome
Stock price: 4.61385443482331
P/E ratio: 14.086216811572514
Shares outstanding: 169477587
Market cap (USD): 781944916.3831033
Effective tax rate (%): 25.651955867602812
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -17.009293346847407
Rule of 40 score: -17.009293346847407
Financial ratios for CSBBANK.NS — quarterly report dated 2025-09-30
Total revenue: 87120631.3416009
Net income: 18075535.51296505
Capital expenditures: 0
Net tangible assets: 529908680.94701236
Owner earnings: 18075535.51296505
Return on net tangible assets (%): 3.411066125707137
Buffett classification: The Gruesome
Stock price: 4.188275084554679
P/E ratio: 13.09226710082021
Shares outstanding: 169477587
Book value: 529908680.94701195
P/B ratio: 1.3395114678136892
Market cap (USD): 709818755.022548
Debt to equity: 0.9204751196202795
Effective tax rate (%): 25.652677950382564
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 19.2932313409795
Rule of 40 score: 19.2932313409795
Financial ratios for CSBBANK.NS — quarterly report dated 2025-12-31
Total revenue: 81282165.5341428
Net income: 17006795.14314359
Capital expenditures: 0
Owner earnings: 17006795.14314359
Buffett classification: The Gruesome
Stock price: 5.1141806839701465
P/E ratio: 12.169294823192478
Shares outstanding: 169477587
Market cap (USD): 866739001.80127
Effective tax rate (%): 25.65014122918087
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -6.701588036667689
Rule of 40 score: -6.701588036667689
Financial ratios for E2E.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1582487142291969
Shares outstanding: 205390390
Market cap (USD): 32502765.1325333
Buyback yield (%): 0.20059361102532594
Retained earnings: 759343.2678359488
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for E2E.NS — annual report dated 2023-03-31
Total revenue: 8063556.638246042
Gross profit: 5991619.975639464
Operating income: 1579573.6906211937
Net income: 1207052.3751522535
Capital expenditures: 2303398.2947624847
Operating cash flow: 4327563.946406821
Depreciation & amortization: 2449646.7722289893
Net tangible assets: 4371425.09135201
Owner earnings: 1353300.852618758
Return on net tangible assets (%): 30.957887287054124
Capex to operating income (%): 145.8240478705767
Buffett classification: The Gruesome
Stock price: 0.2152253349573691
P/E ratio: 36.622450189204734
Shares outstanding: 205390390
Book value: 6017064.55542022
P/B ratio: 7.346641385948611
Market cap (USD): 44205215.48477467
Debt to equity: 0.11918801783802056
Current ratio: 1.8568545951898825
Quick ratio: 1.8568545951898825
Effective tax rate (%): 25.130324413351264
Interest coverage ratio: 28.895499108734402
COGS to revenue (%): 25.695071735209616
SG&A to revenue (%): 1.6717068115972678
Free cash flow (dilution-adjusted): 1949086.4799025578
Buyback yield (%): 0
Retained earnings: 1908404.384896468
Receivables turnover: 109.5149710504549
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.868271099593617
FCF margin (%): 24.17154820563791
Rule of 40 score: 24.17154820563791
Financial ratios for E2E.NS — annual report dated 2024-03-31
Total revenue: 11327929.008274373
Gross profit: 7067897.829475956
Operating income: 3923851.7807890633
Net income: 2622244.8734860294
Capital expenditures: 17447199.904065236
Operating cash flow: 5140100.731502579
Depreciation & amortization: 1888463.8445856818
Net tangible assets: 7030639.16536755
Owner earnings: -12936491.185993526
Return on net tangible assets (%): -184.00163742889552
Capex to operating income (%): 444.64472357201805
Buffett classification: The Gruesome
Stock price: 1.0754558541266794
P/E ratio: 84.23633488249
Shares outstanding: 205390390
Book value: 8496366.470799856
P/B ratio: 25.997971964369277
Market cap (USD): 220888297.3068618
Debt to equity: 2.032837834786143
Current ratio: 0.674014781340394
Quick ratio: 0.674014781340394
Effective tax rate (%): 27.627076010617525
Interest coverage ratio: 9.114230801370436
COGS to revenue (%): 37.60644311671374
SG&A to revenue (%): 2.8095478046570324
Free cash flow (dilution-adjusted): -12539309.269696606
Buyback yield (%): 0
Retained earnings: 4501127.233481233
Receivables turnover: 36.84658891445957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.521134995561848
FCF margin (%): -110.69374870320421
Revenue growth (%): 40.48303393251029
Rule of 40 score: -70.21071477069393
Financial ratios for E2E.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 56625000
Buffett classification: The Gruesome
Stock price: 3.7230052556139515
Shares outstanding: 205390390
Book value: 58218072.14524605
P/B ratio: 13.134572706475995
Market cap (USD): 764669501.4225992
Debt to equity: 0.37176132130848133
Current ratio: 3.721938114732735
Quick ratio: 3.721938114732735
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for E2E.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.718382095815363
Shares outstanding: 205390390
Market cap (USD): 969110338.8285347
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for E2E.NS — annual report dated 2025-03-31
Total revenue: 19167734.393266305
Gross profit: 12851028.758475566
Operating income: 4276911.386485854
Net income: 5552291.325695581
Capital expenditures: 14714110.357727379
Operating cash flow: 10342097.264437689
Depreciation & amortization: 7023158.756137479
Net tangible assets: 184457142.85714284
Owner earnings: -2138660.275894318
Return on net tangible assets (%): -1.1594347840195343
Capex to operating income (%): 344.0358947866185
Buffett classification: The Gruesome
Stock price: 2.473800910257906
P/E ratio: 91.51085631778754
Shares outstanding: 205390390
Book value: 186202209.492635
P/B ratio: 2.728726662936421
Market cap (USD): 508094933.7402263
Debt to equity: 0.0458097719720008
Current ratio: 1.6952594199609696
Quick ratio: 1.6952594199609696
Effective tax rate (%): 24.361775657175983
Interest coverage ratio: 2.7673542560192437
COGS to revenue (%): 32.9548892174227
SG&A to revenue (%): 3.1815531517289495
Free cash flow (dilution-adjusted): -4653834.463408931
Buyback yield (%): 0
Retained earnings: 9940285.246668225
Receivables turnover: 16.817354736140313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.194316753975219
FCF margin (%): -24.279522910354185
Revenue growth (%): 69.20775526811144
Rule of 40 score: 44.92823235775725
Financial ratios for E2E.NS — quarterly report dated 2025-03-31
Total revenue: 3913607.6689268174
Gross profit: 2178173.953705868
Operating income: -660182.3708206686
Net income: 1591337.3860182369
Capital expenditures: 0
Depreciation & amortization: 2219920.5050268876
Net tangible assets: 184457142.85714284
Owner earnings: 3811257.8910451243
Return on net tangible assets (%): 2.066202388267958
Buffett classification: The Gruesome
Stock price: 2.473800910257906
P/E ratio: 79.82200038226267
Shares outstanding: 205390390
Book value: 186202209.492635
P/B ratio: 2.728726662936421
Market cap (USD): 508094933.7402263
Debt to equity: 0.0458097719720008
Current ratio: 1.6952594199609696
Quick ratio: 1.6952594199609696
Effective tax rate (%): 22.60593690123548
Interest coverage ratio: -2.5673758865248226
COGS to revenue (%): 44.34357917376109
Buyback yield (%): 0
Retained earnings: 9940285.246668225
Receivables turnover: 3.433714549464075
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.33871387692256205
Rule of 40 score: 0
Financial ratios for E2E.NS — quarterly report dated 2025-06-30
Total revenue: 4225391.996255559
Gross profit: 1649531.9447694828
Operating income: -1979709.8057570795
Net income: -332483.03299789375
Capital expenditures: 0
Depreciation & amortization: 3210039.7846945943
Owner earnings: 2877556.7516967007
Buffett classification: The Gruesome
Stock price: 3.1032061783290428
P/E ratio: 506.3085540342186
Shares outstanding: 205390390
Market cap (USD): 637368727.2174116
Interest coverage ratio: -9.242611308385687
COGS to revenue (%): 60.96144579647854
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.966673047077263
Rule of 40 score: 7.966673047077263
Financial ratios for E2E.NS — quarterly report dated 2025-09-30
Total revenue: 4938545.659526493
Gross profit: 2462593.0101465615
Operating income: -2795749.718151071
Net income: -1517564.825253664
Capital expenditures: 0
Depreciation & amortization: 4825118.376550169
Net tangible assets: 176095073.28072152
Owner earnings: 3307553.5512965047
Buffett classification: The Gruesome
Stock price: 3.6125140924464487
Shares outstanding: 205390390
Book value: 177615073.28072155
P/B ratio: 4.177436433873919
Market cap (USD): 741975678.3280722
Debt to equity: 0.1016577721466376
Current ratio: 16.392197085309387
Quick ratio: 16.392197085309387
Interest coverage ratio: -12.417776664997497
COGS to revenue (%): 50.13525884090593
Buyback yield (%): 0
Receivables turnover: 6.9734148399318645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4315134067823172
Revenue growth (%): 16.877810719169112
Rule of 40 score: 16.877810719169112
Financial ratios for E2E.NS — quarterly report dated 2025-12-31
Total revenue: 7800189.3728417065
Gross profit: 4877977.052467417
Operating income: -891545.0595967473
Net income: -634855.7424529353
Capital expenditures: 0
Depreciation & amortization: 5307853.403141362
Owner earnings: 4672997.660688426
Buffett classification: The Gruesome
Stock price: 2.218447142698006
Shares outstanding: 205390390
Market cap (USD): 455647723.8331291
Interest coverage ratio: -1.690871062472271
COGS to revenue (%): 37.463350961050985
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 57.94506947192196
Rule of 40 score: 57.94506947192196
Financial ratios for EME.L — annual report dated 2022-03-31
Total revenue: 0
Operating income: -812781.954887218
Net income: -6097744.360902255
Capital expenditures: 10820300.7518797
Operating cash flow: -663157.894736842
Net tangible assets: 14042105.263157895
Owner earnings: -16918045.112781957
Return on net tangible assets (%): -120.4808310130649
Buffett classification: The Gruesome
Stock price: 0.0013157894736842105
Shares outstanding: 5719672441
Book value: 14042105.263157897
P/B ratio: 0.5359513156859069
Market cap (USD): 7525884.790789474
Debt to equity: 0.220871707003641
Current ratio: 0.008749602290804964
Quick ratio: 0.008749602290804964
Interest coverage ratio: -4.2727272727272725
Free cash flow (dilution-adjusted): -11533082.706766916
Buyback yield (%): 0
Retained earnings: -18792481.20300752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.788177339901476
Rule of 40 score: 0
Financial ratios for EME.L — annual report dated 2023-03-31
Total revenue: 0
Operating income: -675838.9261744966
Net income: -13957046.979865773
Capital expenditures: 823489.9328859061
Operating cash flow: -755704.6979865772
Net tangible assets: 1541610.7382550335
Owner earnings: -14780536.912751678
Return on net tangible assets (%): -958.7723117109274
Buffett classification: The Gruesome
Stock price: 0.0001234567901234568
Shares outstanding: 5719672441
Book value: 1541610.7382550333
P/B ratio: 0.45804844413754936
Market cap (USD): 706132.4001234568
Debt to equity: 1.7744884632128866
Current ratio: 0.014304291287386216
Quick ratio: 0.014304291287386216
Interest coverage ratio: -0.4363084922010399
Free cash flow (dilution-adjusted): -1593959.731543624
Buyback yield (%): 0
Retained earnings: -30379194.630872484
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.83979103178059
Rule of 40 score: 0
Financial ratios for EME.L — annual report dated 2024-03-31
Total revenue: 0
Operating income: -716993.4640522875
Net income: -6265359.4771241825
Capital expenditures: 630065.3594771242
Operating cash flow: -540522.8758169934
Net tangible assets: -2849019.6078431373
Owner earnings: -6895424.836601307
Buffett classification: The Gruesome
Stock price: 0.00012658227848101267
Shares outstanding: 5719672441
Book value: -2849019.6078431373
Market cap (USD): 724009.1697468355
Debt to equity: -1.7421426932782746
Current ratio: 0.09316654219566842
Quick ratio: 0.09316654219566842
Interest coverage ratio: -0.9838565022421524
Free cash flow (dilution-adjusted): -1309150.3267973855
Buyback yield (%): 0
Retained earnings: -35802614.37908497
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EME.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -4039310.3448275863
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 5719672441
Book value: -4039310.344827587
Market cap (USD): 0
Debt to equity: -1.4638893631551988
Current ratio: 0.05503366863413418
Quick ratio: 0.05503366863413418
Retained earnings: -38852413.79310345
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EME.L — annual report dated 2025-03-31
Total revenue: 0
Operating income: -515094.3396226415
Net income: -2106918.2389937104
Capital expenditures: 891823.8993710692
Operating cash flow: -589308.1761006289
Net tangible assets: -2873584.9056603773
Owner earnings: -2998742.1383647798
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 5719672441
Book value: -2873584.905660377
Market cap (USD): 0
Debt to equity: -1.9562267454585252
Current ratio: 0.1434966426262124
Quick ratio: 0.1434966426262124
Interest coverage ratio: -0.6768595041322315
Free cash flow (dilution-adjusted): -1529559.748427673
Retained earnings: -36552201.25786164
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EME.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -2873584.9056603773
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 5719672441
Book value: -2873584.905660377
Market cap (USD): 0
Debt to equity: -1.9562267454585252
Current ratio: 0.1434966426262124
Quick ratio: 0.1434966426262124
Retained earnings: -36552201.25786164
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.010405405405405407
Shares outstanding: 49051862
Market cap (USD): 510404.51000000007
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.L — annual report dated 2022-12-31
Total revenue: 314819277.1084337
Gross profit: 78795180.72289157
Operating income: 10602409.638554217
Net income: 5783132.530120483
Capital expenditures: 2530120.481927711
Operating cash flow: 17710843.373493977
Depreciation & amortization: 9518072.289156627
Net tangible assets: 3253012.048192771
Owner earnings: 12771084.337349398
Return on net tangible assets (%): 392.5925925925926
Capex to operating income (%): 23.863636363636363
Buffett classification: The Great
Stock price: 0.006265060240963855
P/E ratio: 0.05313951716666666
Shares outstanding: 49051862
Book value: 59036144.57831325
P/B ratio: 0.005205503722448979
Market cap (USD): 307312.87036144576
Debt to equity: 0.7775510204081635
Current ratio: 0.9971098265895955
Quick ratio: 0.9971098265895955
Effective tax rate (%): 36.84210526315789
Interest coverage ratio: 5.866666666666666
COGS to revenue (%): 74.97129735935707
SG&A to revenue (%): 21.125143513203216
Free cash flow (dilution-adjusted): 14819277.108433735
Buyback yield (%): 156.81989181792312
Retained earnings: 28192771.08433735
Receivables turnover: 7.846846846846846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.117216117216117
FCF margin (%): 4.707233065442021
Rule of 40 score: 4.707233065442021
Financial ratios for EMR.L — annual report dated 2023-12-31
Total revenue: 316835443.03797466
Gross profit: 72784810.12658228
Operating income: 4936708.860759494
Net income: -1645569.6202531646
Capital expenditures: 1772151.8987341772
Operating cash flow: 6962025.316455696
Depreciation & amortization: 10253164.556962024
Net tangible assets: -253164.5569620253
Owner earnings: 6835443.037974683
Capex to operating income (%): 35.8974358974359
Buffett classification: The Good
Stock price: 0.004177215189873417
Shares outstanding: 49051862
Book value: 54303797.46835442
P/B ratio: 0.003773220153846154
Market cap (USD): 204900.18303797464
Debt to equity: 0.8181818181818183
Current ratio: 1.10752688172043
Quick ratio: 1.10752688172043
Effective tax rate (%): 1400.0000000000002
Interest coverage ratio: 1.772727272727273
COGS to revenue (%): 77.02756691969637
SG&A to revenue (%): 20.93487814622453
Free cash flow (dilution-adjusted): 5569620.253164556
Buyback yield (%): 247.1101325615758
Retained earnings: 24303797.46835443
Receivables turnover: 8.074193548387097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.83012259194396
FCF margin (%): 1.757890531362365
Revenue growth (%): 0.6404201000838017
Rule of 40 score: 2.398310631446167
Financial ratios for EMR.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -9875000
Buffett classification: The Gruesome
Stock price: 0.003375
Shares outstanding: 49051862
Book value: 39250000
P/B ratio: 0.004217835267515924
Market cap (USD): 165550.03425
Debt to equity: 1.2388535031847134
Current ratio: 1.105263157894737
Quick ratio: 1.105263157894737
Buyback yield (%): 0
Retained earnings: 10500000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.L — annual report dated 2024-12-31
Total revenue: 307750000
Gross profit: 63000000
Operating income: 3250000
Net income: -11125000
Capital expenditures: 1000000
Operating cash flow: 1750000
Depreciation & amortization: 10000000
Net tangible assets: -9875000
Owner earnings: -2125000
Capex to operating income (%): 30.76923076923077
Buffett classification: The Good
Stock price: 0.003375
Shares outstanding: 49051862
Book value: 39250000
P/B ratio: 0.004217835267515924
Market cap (USD): 165550.03425
Debt to equity: 1.2388535031847134
Current ratio: 1.105263157894737
Quick ratio: 1.105263157894737
Interest coverage ratio: 1.0833333333333333
COGS to revenue (%): 79.52883834281073
SG&A to revenue (%): 18.92770105605199
Free cash flow (dilution-adjusted): 625000
Buyback yield (%): 151.01174767651852
Retained earnings: 10500000
Receivables turnover: 8.289562289562289
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.284552845528456
FCF margin (%): 0.20308692120227456
Revenue growth (%): -2.86755892928485
Rule of 40 score: -2.6644720080825754
Financial ratios for EMR.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -13561643.83561644
Buffett classification: The Gruesome
Stock price: 0.003561643835616438
Shares outstanding: 49051862
Book value: 39178082.19178082
P/B ratio: 0.004459260181818182
Market cap (USD): 174705.2619178082
Debt to equity: 1.2622377622377623
Current ratio: 1.1102204408817637
Quick ratio: 1.1102204408817637
Buyback yield (%): 0
Retained earnings: 9589041.095890412
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 63177272.72727273
Buffett classification: The Gruesome
Stock price: 23.75
Shares outstanding: 355188058
Market cap (USD): 8435716377.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVO — annual report dated 2022-12-31
Total revenue: 799412765.9574468
Gross profit: 185175531.91489363
Operating income: 22180851.063829787
Net income: -186867021.27659574
Capital expenditures: 192929787.23404256
Operating cash flow: 218947872.34042555
Depreciation & amortization: 88506382.9787234
Net tangible assets: 945261702.1276597
Owner earnings: -291290425.5319149
Return on net tangible assets (%): -30.815849714027184
Capex to operating income (%): 869.8033573141487
Buffett classification: The Gruesome
Stock price: 8.09
Shares outstanding: 355188058
Book value: 1262961702.1276596
P/B ratio: 2.2751848962475907
Market cap (USD): 2873471389.22
Debt to equity: 0.4267864122157981
Current ratio: 3.1793068527062
Quick ratio: 3.0909903880890472
Interest coverage ratio: 1.585551330798479
COGS to revenue (%): 76.83605518944758
R&D to revenue (%): 10.199241996784874
SG&A to revenue (%): 20.785204032747444
Free cash flow (dilution-adjusted): 15465957.446808511
Buyback yield (%): 0
Retained earnings: -417422340.4255319
Inventory turnover: 19.35902766135792
Receivables turnover: 2.724898557136174
Capitalized R&D asset: 81534042.5531915
ROCI (R&D-adjusted, %): 3.604111780666737
FCF margin (%): 1.934664807145671
Rule of 40 score: 1.934664807145671
Financial ratios for EVO — annual report dated 2023-12-31
Total revenue: 868251111.111111
Gross profit: 194501111.1111111
Operating income: -29586666.666666664
Net income: -93236666.66666667
Capital expenditures: 236434444.44444445
Operating cash flow: 40487777.777777776
Depreciation & amortization: 103310000
Net tangible assets: 920910000
Owner earnings: -226361111.1111111
Return on net tangible assets (%): -24.58015561901935
Buffett classification: The Gruesome
Stock price: 11.73
Shares outstanding: 355188058
Book value: 1244342222.2222223
P/B ratio: 3.3482396128128378
Market cap (USD): 4166355920.34
Debt to equity: 0.5591602167320886
Current ratio: 1.9440690698770697
Quick ratio: 1.8775779048717853
Interest coverage ratio: -2.268336314847943
COGS to revenue (%): 77.5985186057285
R&D to revenue (%): 8.769736353794217
SG&A to revenue (%): 21.705190254739414
Free cash flow (dilution-adjusted): -210210000
Buyback yield (%): 0
Retained earnings: -529211111.1111111
Inventory turnover: 19.630139203625767
Receivables turnover: 3.5215390785898086
Capitalized R&D asset: 130771141.84397164
ROCI (R&D-adjusted, %): -0.2834930663193623
Rosenberg metric: 0.11437650954365006
FCF margin (%): -24.210737804987296
Revenue growth (%): 8.611114068364595
Rule of 40 score: -15.599623736622702
Financial ratios for EVO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.65
Shares outstanding: 355188058
Market cap (USD): 1296436411.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 355188058
Market cap (USD): 1477582321.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EVO — annual report dated 2024-12-31
Total revenue: 830173958.3333334
Gross profit: 119667708.33333334
Operating income: -82207291.66666667
Net income: -204247916.6666667
Capital expenditures: 120279166.66666667
Operating cash flow: 18979166.666666668
Depreciation & amortization: 105852083.33333334
Net tangible assets: 670031250
Owner earnings: -218675000
Return on net tangible assets (%): -32.6365374749312
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 355188058
Book value: 992213541.6666667
P/B ratio: 1.4891777417168053
Market cap (USD): 1477582321.28
Debt to equity: 0.46564447127371983
Current ratio: 1.9790878883294398
Quick ratio: 1.8887705500819827
Interest coverage ratio: -6.745790238481922
COGS to revenue (%): 85.58522498422143
R&D to revenue (%): 6.381318172521573
SG&A to revenue (%): 23.614654057194336
Free cash flow (dilution-adjusted): -124012500.00000001
Buyback yield (%): 0
Retained earnings: -700385416.6666667
Inventory turnover: 21.91652207441681
Receivables turnover: 3.6494337877379444
Capitalized R&D asset: 130898309.04255319
ROCI (R&D-adjusted, %): -5.637237612336163
Rosenberg metric: -0.9827965168031051
FCF margin (%): -14.938134201290646
Revenue growth (%): -4.385500034552204
Rule of 40 score: -19.32363423584285
Financial ratios for EVO — quarterly report dated 2025-03-31
Total revenue: 217367391.3043478
Gross profit: 36126086.956521735
Operating income: -21539130.43478261
Net income: -34322826.08695652
Capital expenditures: 19673913.04347826
Operating cash flow: -34573913.04347826
Net tangible assets: 656368478.2608695
Owner earnings: -53996739.13043478
Return on net tangible assets (%): -8.22658931969218
Buffett classification: The Gruesome
Stock price: 3.34
Shares outstanding: 355188058
Book value: 991457608.6956522
P/B ratio: 1.1965495078309163
Market cap (USD): 1186328113.72
Debt to equity: 0.0667901124935728
Current ratio: 2.0281211475961
Quick ratio: 1.934240165863499
Interest coverage ratio: -8.23265475695887
COGS to revenue (%): 83.38017181890008
R&D to revenue (%): 7.465321185330385
SG&A to revenue (%): 24.770724779725768
Free cash flow (dilution-adjusted): -58310869.56521739
Buyback yield (%): 0
Retained earnings: -765159782.6086956
Inventory turnover: 4.976184791691536
Receivables turnover: 0.7911304519829888
Capitalized R&D asset: 16227173.913043477
ROCI (R&D-adjusted, %): -0.6153388013017151
FCF margin (%): -26.825950854594005
Rule of 40 score: -26.825950854594005
Financial ratios for EVO — quarterly report dated 2025-06-30
Total revenue: 201452941.1764706
Gross profit: 10110588.235294119
Operating income: -33645882.35294118
Net income: -51150588.23529412
Capital expenditures: 22955294.11764706
Operating cash flow: 31242352.94117647
Net tangible assets: 637050588.2352941
Owner earnings: -74105882.35294119
Return on net tangible assets (%): -11.632652684337565
Buffett classification: The Gruesome
Stock price: 4.2
Shares outstanding: 355188058
Book value: 995043529.4117649
P/B ratio: 1.4992206868395943
Market cap (USD): 1491789843.6000001
Debt to equity: 0.12634623137976816
Current ratio: 1.5774260474705428
Quick ratio: 1.4872267964560197
Interest coverage ratio: -4.77047539616347
COGS to revenue (%): 94.98116623353869
R&D to revenue (%): 4.795164539959703
SG&A to revenue (%): 24.29993868076036
Free cash flow (dilution-adjusted): 3171764.7058823532
Buyback yield (%): 0
Retained earnings: -879322352.9411765
Inventory turnover: 4.705638978097966
Receivables turnover: 1.0157190734644246
Capitalized R&D asset: 20532206.521739133
ROCI (R&D-adjusted, %): -1.9218157633282558
Rosenberg metric: -1.6032057621762617
FCF margin (%): 1.5744444768884864
Revenue growth (%): -7.321452418589559
Rule of 40 score: -5.747007941701073
Financial ratios for EVO — quarterly report dated 2025-09-30
Total revenue: 192808235.29411766
Gross profit: -72941.17647058824
Operating income: -52482352.941176474
Net income: -50690588.23529412
Capital expenditures: 23775294.11764706
Operating cash flow: -79478823.52941176
Net tangible assets: 587741176.4705882
Owner earnings: -74465882.35294119
Return on net tangible assets (%): -12.669842667840989
Buffett classification: The Gruesome
Stock price: 3.63
Shares outstanding: 355188058
Book value: 941336470.5882354
P/B ratio: 1.3696830950725876
Market cap (USD): 1289332650.54
Debt to equity: 0.1210706679864423
Current ratio: 2.1179836941572954
Quick ratio: 2.034707998301586
Interest coverage ratio: -19.54007884362681
COGS to revenue (%): 100.03783094449223
R&D to revenue (%): 5.316468054208082
SG&A to revenue (%): 25.817178909858622
Free cash flow (dilution-adjusted): -104660000
Buyback yield (%): 0
Retained earnings: -930012941.1764706
Inventory turnover: 5.257471780400205
Receivables turnover: 0.8507069889124206
Capitalized R&D asset: 22077755.626598466
ROCI (R&D-adjusted, %): -3.255897118069163
Rosenberg metric: -1.0541955912799905
FCF margin (%): -54.28191375765008
Revenue growth (%): -4.2911787893830144
Rule of 40 score: -58.5730925470331
Financial ratios for EVO — quarterly report dated 2025-12-31
Total revenue: 297968235.2941176
Gross profit: 92309411.76470588
Operating income: 43774117.64705882
Net income: 17204705.88235294
Capital expenditures: 17067058.82352941
Operating cash flow: 74858823.52941176
Net tangible assets: 599727058.8235295
Owner earnings: 137647.05882352963
Return on net tangible assets (%): 0.022951617206258566
Capex to operating income (%): 38.988927112448934
Buffett classification: The Good
Stock price: 3.08
P/E ratio: 15.89651148529814
Shares outstanding: 355188058
Book value: 957298823.5294118
P/B ratio: 1.1427771472722268
Market cap (USD): 1093979218.64
Debt to equity: 0.5501865543244226
Current ratio: 2.072803294989595
Quick ratio: 1.9931535506447076
Effective tax rate (%): 50.36654900896009
Interest coverage ratio: 9.903646526483897
COGS to revenue (%): 69.02038511803468
R&D to revenue (%): 3.880397831588839
SG&A to revenue (%): 17.51153893229835
Free cash flow (dilution-adjusted): 56600000
Buyback yield (%): 0
Retained earnings: -912808235.2941177
Inventory turnover: 5.9627519869017975
Receivables turnover: 1.1862237251302032
Capitalized R&D asset: 21618047.05882353
ROCI (R&D-adjusted, %): 2.7941190347387455
Rosenberg metric: 9.01239527143349
FCF margin (%): 18.995313357523305
Revenue growth (%): 54.54123878037914
Rule of 40 score: 73.53655213790245
Financial ratios for EVO — annual report dated 2025-12-31
Total revenue: 927497647.0588236
Gross profit: 134377647.05882353
Operating income: -65668235.29411765
Net income: -121784705.88235295
Capital expenditures: 85091764.70588236
Operating cash flow: -10798823.529411765
Depreciation & amortization: 117030588.23529412
Net tangible assets: 599727058.8235295
Owner earnings: -89845882.35294119
Return on net tangible assets (%): -14.981128670297075
Buffett classification: The Gruesome
Stock price: 3.08
Shares outstanding: 355188058
Book value: 957298823.5294118
P/B ratio: 1.1427771472722268
Market cap (USD): 1093979218.64
Debt to equity: 0.5501865543244226
Current ratio: 2.072803294989595
Quick ratio: 1.9931535506447076
Interest coverage ratio: -3.8649771499792274
COGS to revenue (%): 85.51180722830436
R&D to revenue (%): 4.757773287517457
SG&A to revenue (%): 22.320779630961486
Free cash flow (dilution-adjusted): -112445882.35294119
Buyback yield (%): 0.1664726751256083
Retained earnings: -912808235.2941177
Inventory turnover: 22.995258723607463
Receivables turnover: 3.692406047435273
Capitalized R&D asset: 104749483.21078432
ROCI (R&D-adjusted, %): -4.696873950406176
Rosenberg metric: 0.27767153344614454
FCF margin (%): -12.123576023024635
Revenue growth (%): 11.723288564830238
Rule of 40 score: -0.4002874581943967
Financial ratios for FLOC — quarterly report dated 2025-03-31
Total revenue: 192350000
Gross profit: 65814000
Operating income: 35280000
Net income: 27045000
Capital expenditures: 27644000
Operating cash flow: 42549000
Depreciation & amortization: 36171000
Net tangible assets: -916734000
Owner earnings: 35572000
Return on net tangible assets (%): -3.8802967927446788
Capex to operating income (%): 78.35600907029479
Buffett classification: The Gruesome
Stock price: 25.12
P/E ratio: 9.711803932704752
Shares outstanding: 41824162
Book value: 1305582000
P/B ratio: 0.8047161721285987
Market cap (USD): 1050622949.44
Debt to equity: 0.16951214094557063
Current ratio: 3.4479123124796804
Quick ratio: 1.6254702521945101
Effective tax rate (%): 8.917926784090527
Interest coverage ratio: 6.575955265610438
COGS to revenue (%): 65.78424746555757
SG&A to revenue (%): 15.874187678710683
Free cash flow (dilution-adjusted): 9718000
Buyback yield (%): 0
Retained earnings: -370103000
Inventory turnover: 0.8061877213996279
Receivables turnover: 1.4322305865183431
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.321532211259431
FCF margin (%): 5.052248505328827
Rule of 40 score: 5.052248505328827
Financial ratios for FLOC — quarterly report dated 2025-06-30
Total revenue: 193215000
Gross profit: 69869000
Operating income: 37186000
Net income: 27352000
Capital expenditures: 35706000
Operating cash flow: 82178000
Depreciation & amortization: 35124000
Net tangible assets: -386519000
Owner earnings: 26770000
Return on net tangible assets (%): -6.9259208473580856
Capex to operating income (%): 96.02000752971549
Buffett classification: The Gruesome
Stock price: 17.51
P/E ratio: 13.462894582789493
Shares outstanding: 41824162
Book value: 1315003000
P/B ratio: 0.5569120957290592
Market cap (USD): 732341076.6200001
Debt to equity: 0.15902777408112376
Current ratio: 3.2485995020451717
Quick ratio: 1.5719366886003912
Effective tax rate (%): 12.423155737704917
Interest coverage ratio: 5.769743987587277
COGS to revenue (%): 63.83872887715757
SG&A to revenue (%): 16.91535336283415
Free cash flow (dilution-adjusted): 43303000
Buyback yield (%): 0
Retained earnings: 132227000
Inventory turnover: 0.8176948676133275
Receivables turnover: 1.5738221686432947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.452672638842536
FCF margin (%): 22.411821028388065
Revenue growth (%): 0.4497010657655316
Rule of 40 score: 22.861522094153596
Financial ratios for FLOC — quarterly report dated 2025-09-30
Total revenue: 176941000
Gross profit: 63805000
Operating income: 34825000
Net income: 34273000
Capital expenditures: 39499000
Operating cash flow: 82467000
Depreciation & amortization: 41569000
Net tangible assets: -160044000
Owner earnings: 36343000
Return on net tangible assets (%): -22.70813026417735
Capex to operating income (%): 113.42139267767408
Buffett classification: The Gruesome
Stock price: 14.67
P/E ratio: 6.919594637870756
Shares outstanding: 41824162
Book value: 1321294000
P/B ratio: 0.4643633109209608
Market cap (USD): 613560456.54
Debt to equity: 0.2003233194126364
Current ratio: 2.904501951770464
Quick ratio: 1.3263419660372124
Effective tax rate (%): -6.886012786527367
Interest coverage ratio: 12.631483496554226
COGS to revenue (%): 63.939957386925585
SG&A to revenue (%): 16.378340802866493
Free cash flow (dilution-adjusted): 40986000
Buyback yield (%): 0
Retained earnings: 315410000
Inventory turnover: 0.7102517421055936
Receivables turnover: 1.48727410271497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.196743709869608
FCF margin (%): 23.163653421196898
Revenue growth (%): -8.422741505576688
Rule of 40 score: 14.74091191562021
Financial ratios for FLOC — quarterly report dated 2025-12-31
Total revenue: 197213000
Gross profit: 68843000
Operating income: 42463000
Net income: 42985000
Capital expenditures: 23971000
Operating cash flow: 87176000
Depreciation & amortization: 41801000
Net tangible assets: -294503000
Owner earnings: 60815000
Return on net tangible assets (%): -20.65004431194249
Capex to operating income (%): 56.45149895202882
Buffett classification: The Good
Stock price: 18.61
P/E ratio: 5.912025026166875
Shares outstanding: 41824162
Book value: 1357924000
P/B ratio: 0.5731894088476233
Market cap (USD): 778347654.8199999
Debt to equity: 0.15417873165213958
Current ratio: 3.3353245055184524
Quick ratio: 1.4177744164284525
Effective tax rate (%): -13.647780451048305
Interest coverage ratio: 9.71248856358646
COGS to revenue (%): 65.09205782580256
SG&A to revenue (%): 13.376400135893679
Free cash flow (dilution-adjusted): 61479000
Buyback yield (%): 0
Retained earnings: 159338000
Inventory turnover: 0.8581455979677786
Receivables turnover: 1.9630020405116209
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.707512401647602
FCF margin (%): 31.173908413745544
Revenue growth (%): 11.456926320072792
Rule of 40 score: 42.63083473381833
Financial ratios for FLOC — annual report dated 2025-12-31
Total revenue: 759719000
Gross profit: 268331000
Operating income: 149754000
Net income: 131655000
Capital expenditures: 126820000
Operating cash flow: 294370000
Depreciation & amortization: 154665000
Net tangible assets: -294503000
Owner earnings: 159500000
Return on net tangible assets (%): -54.15904082471147
Capex to operating income (%): 84.68555097025789
Buffett classification: The Gruesome
Stock price: 18.61
P/E ratio: 5.912025026166875
Shares outstanding: 41824162
Book value: 1357924000
P/B ratio: 0.5731894088476233
Market cap (USD): 778347654.8199999
Debt to equity: 0.15417873165213958
Current ratio: 3.3353245055184524
Quick ratio: 1.4177744164284525
Effective tax rate (%): -0.6436669138388387
Interest coverage ratio: 7.90717566925392
COGS to revenue (%): 64.68023045362825
SG&A to revenue (%): 15.60800769758292
Free cash flow (dilution-adjusted): 155486000
Buyback yield (%): 1.9271594007010773
Retained earnings: 159338000
Inventory turnover: 3.284898723176683
Receivables turnover: 7.562026576419648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.548567274953134
FCF margin (%): 20.466251337665636
Revenue growth (%): 41.929800963237795
Rule of 40 score: 62.396052300903435
Financial ratios for FSUN — annual report dated 2022-12-31
Total revenue: 322733000
Net income: 59182000
Capital expenditures: 2194000
Operating cash flow: 96915000
Depreciation & amortization: 12168000
Net tangible assets: 590914000
Owner earnings: 69156000
Return on net tangible assets (%): 11.703225850123706
Buffett classification: The Gruesome
Stock price: 36.45
P/E ratio: 27.175750122503466
Shares outstanding: 44123875
Book value: 774536000
P/B ratio: 2.076488689680015
Market cap (USD): 1608315243.7500002
Debt to equity: 0.9752768108906493
Effective tax rate (%): 20.048093809948394
COGS to revenue (%): 0
SG&A to revenue (%): 43.9995290224427
Free cash flow (dilution-adjusted): 93271000
Buyback yield (%): 0.036000404911289946
Retained earnings: 357797000
Receivables turnover: 10.88695857509108
Capitalized R&D asset: 0
FCF margin (%): 28.900360359802065
Rule of 40 score: 28.900360359802065